Craig A. Wheeler
(Cornell MS '82, '84 ChemE)
 
Momenta Pharmaceuticals, Inc.

Wheeler joined Momenta as CEO in September of 2006. He led the
com¬pany through the launch of its first complex drug products, including
the first generic versions of LOVENOX® and COPAXONE®. In 2011,
he was an E&Y Entrepreneur of the Year Regional Award winner. In May
2012, the Boston Globe named Momenta the number one company in their
annual Globe 100 survey of top performing companies. Prior to joining
Momenta, Wheeler was president of Chiron BioPharmaceuticals where
during his five-year tenure the pharmaceutical division’s global sales
more than doubled. Before that, he was a senior member of The Boston
Consulting Group’s health care practice. He began his career at Merck’s
MSDRL research unit. Wheeler is currently a member of the board of directors
of Amicus Therapeutics. He also previously served on the board of
the Association for Accessible Medicines as well as being chairman of the
board of Avanir Pharmaceuticals.

301 Binney Street
Cambridge, MA 02142
617 395-5158
Craig_wheeler@comcast.net

 

  • No labels